Cross-reactivity between nickel and palladium demonstrated by systemic administration of nickel.
Concomitant patch test reactions to nickel and palladium have frequently been reported in patients undergoing investigation because of suspected allergic contact dermatitis. Theoretically, these reactions can be explained by multiple, concomitant, simultaneous sensitization as well as cross-sensitization. We studied whether concomitant reactions to nickel and palladium could represent cross-sensitization in females hypersensitive to combinations of nickel, palladium and cobalt. Females were patch tested with serial dilutions of nickel sulfate, cobalt chloride and palladium chloride on the upper back. 1 month later, when the patch test reactions were gone, the patients were randomized into 2 groups that were challenged orally with either nickel or placebo. 1 day later, the areas of previous positive patch test reactions were read in a blind way looking for flare-up reactions. Nickel provocation but not placebo yielded flare-up reactions on sites previously tested with nickel (P = 0.012) and palladium (P = 0.006), but were also observed on sites previously tested with cobalt, even though this was not statistically significant. Flare-up reactions of previous patch test reactions to nickel and palladium after oral challenge with nickel speak in favour of a cross-reactivity mechanism.
Hindsén
M
M
Department of Occupational and Environmental Dermatology, University Hospital, Malmö, Sweden. monica.hindsen@derm.mas.lu.se
Spirén
A
A
Bruze
M
M
D000284:Administration, Oral; D000328:Adult; D000485:Allergens / Q000008:administration & dosage / Q000009:adverse effects; D003035:Cobalt; D003429:Cross Reactions; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000276:immunology / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007509:Irritants / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009532:Nickel / Q000008:administration & dosage / Q000009:adverse effects; D010165:Palladium / Q000008:administration & dosage / Q000009:adverse effects; D010328:Patch Tests / Q000379:methods; D013054:Spectrophotometry, Atomic
D000485:Allergens; D007509:Irritants; D003035:Cobalt; C029938:nickel sulfate; D010165:Palladium; D009532:Nickel; C018021:cobaltous chloride; C008756:palladium chloride